Loading...
Market
What will be the primary application of the third set of teeth drug by end of 2025?
2
Resolution / Starting Odds
Dental implants alternative • 25%
Cosmetic dentistry • 25%
Orthodontic applications • 25%
Other • 25%
Official statements from the research team or commercial partners
Story
Japanese Researchers Test Drug to Regrow Third Set of Teeth, Targeting USAG-1 Protein in Clinical Trials
Dec 13, 2024, 01:30 PM
Japanese researchers are conducting clinical trials on a pioneering drug designed to stimulate the growth of a third set of teeth, which could provide a natural alternative to dentures and implants. The drug targets the USAG-1 protein and utilizes RNA technology to promote tooth regeneration. This development is significant as it challenges the long-held belief that humans and most mammals only grow two sets of teeth. Additionally, a study has identified 18 genomic regions linked to tooth shape and size, including a gene inherited from Neanderthals that influences these characteristics. The research is led by Katsu Takahashi at a medical research facility in Japan.
View original story
Similar markets
Significant tooth regrowth • 25%
Moderate tooth regrowth • 25%
Minimal tooth regrowth • 25%
No tooth regrowth • 25%
Chronic Disease Management • 25%
Mental Health • 25%
Telemedicine • 25%
Other • 25%
United States • 25%
European Union • 25%
China • 25%
Other • 25%
Age-related macular degeneration • 25%
Diabetic retinopathy • 25%
Retinitis pigmentosa • 25%
No other application • 25%
Advanced Synovial Sarcoma • 25%
Other Sarcomas • 25%
Other Solid Tumors • 25%
Combination Therapies • 25%
Mild discomfort • 25%
Gum irritation • 25%
Severe pain • 25%
No significant side effects • 25%
Weight Loss • 25%
Type 2 Diabetes • 25%
Both equally • 25%
Other • 25%
Phase 1 completion • 25%
Phase 2 completion • 25%
Phase 3 completion • 25%
No significant milestone • 25%
COVID-19 prevention • 25%
Influenza prevention • 25%
Bacterial infection prevention • 25%
General respiratory health • 25%